Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1995
Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancerA D Seidman, A Tiersten, C Hudis, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2000
Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21T Gilewski, S Adluri, G Ragupathi, et al.Cancer|May 1, 1995
A phase I study of anti-GD3 ganglioside monoclonal antibody R24 and recombinant human macrophage-colony stimulating factor in patients with metastatic melanomaL M Minasian, T J Yao, T A Steffens, et al.Oncogene|December 1, 1993
Over-expression of transforming growth factor alpha antagonizes the anti-tumorigenic but not the differentiation actions of retinoic acid in a human teratocarcinoma cellJ Baselga, W J Maerz, D Moy, et al.Journal of the National Cancer Institute|September 6, 1995
Quality of life in phase II trials: a study of methodology and predictive value in patients with advanced breast cancer treated with paclitaxel plus granulocyte colony-stimulating factorA D Seidman, R Portenoy, T J Yao, et al.Anaesthesia|September 7, 2012
A randomised comparison of two intranasal dexmedetomidine doses for premedication in childrenV M Yuen, T W Hui, M G Irwin, et al.Cancer Research|July 1, 1995
GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21F Helling, S Zhang, A Shang, et al.Journal of AIDS and Immune Research|May 2, 2017
Newborn Hearing Screenings in Human Immunodeficiency Virus-Exposed Uninfected InfantsP Torre, B Zeldow, T J Yao, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cellsF Shapiro, T J Yao, C Moskowitz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 1995
Rapidly cycled courses of high-dose alkylating agents supported by filgrastim and peripheral blood progenitor cells in patients with metastatic breast cancerL Vahdat, G Raptis, D Fennelly, et al.Pageof 15